Ingevity Corporation (NYSE:NGVT) Stock Has Average Price Target of $80.00

Key Points

• Analyst sentiment is neutral: Five brokerages give Ingevity an average “Hold” rating, with three holds and two buys. The average 12-month price target is $80, compared with a recent share price of $71.53.
• Quarterly results exceeded expectations: Ingevity reported $1.74 in adjusted earnings per share versus the $1.33 consensus estimate, while revenue of $314.1 million topped forecasts of $312.2 million. Fiscal 2026 guidance is 5.00–5.45 EPS.
• Insiders have been selling while institutions maintain strong ownership: Company insiders sold 17,801 shares worth approximately $1.35 million during the last quarter, whereas institutional investors and hedge funds own 91.59% of the stock.

Shares of Ingevity Corporation (NYSE:NGVT - Get Free Report) have received an average rating of "Hold" from the five brokerages that are currently covering the company, MarketBeat.com reports. Three equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The average 1 year price objective among brokers that have issued a report on the stock in the last year is $80.00.

A number of research firms have recently commented on NGVT. Weiss Ratings upgraded Ingevity from a "sell (d-)" rating to a "hold (c-)" rating in a research report on Friday, July 31st. Wall Street Zen cut Ingevity from a "strong-buy" rating to a "buy" rating in a research report on Saturday, August 1st.

Insider Buying and Selling

In other news, CEO David H. Li sold 5,000 shares of the firm's stock in a transaction that occurred on Monday, August 17th. The shares were sold at an average price of $75.83, for a total transaction of $379,150.00. Following the transaction, the chief executive officer directly owned 120,636 shares in the company, valued at approximately $9,147,827.88. This trade represents a 3.98% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Ryan C. Fisher sold 2,709 shares of Ingevity stock in a transaction on Monday, August 3rd. The shares were sold at an average price of $73.72, for a total transaction of $199,707.48. Following the completion of the transaction, the senior vice president directly owned 15,722 shares in the company, valued at $1,159,025.84. The trade was a 14.70% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last quarter, insiders sold 17,801 shares of company stock valued at $1,347,481. 0.88% of the stock is owned by company insiders.

Institutional Trading of Ingevity

A number of large investors have recently bought and sold shares of NGVT. Los Angeles Capital Management LLC lifted its position in Ingevity by 94.2% during the 4th quarter. Los Angeles Capital Management LLC now owns 30,877 shares of the company's stock worth $1,827,000 after acquiring an additional 14,975 shares during the period. Canada Pension Plan Investment Board acquired a new position in shares of Ingevity in the second quarter valued at approximately $1,113,000. Principal Financial Group Inc. raised its stake in shares of Ingevity by 4.0% during the first quarter. Principal Financial Group Inc. now owns 678,037 shares of the company's stock worth $48,297,000 after purchasing an additional 25,800 shares during the last quarter. Pacer Advisors Inc. acquired a new stake in shares of Ingevity during the fourth quarter worth $9,660,000. Finally, Illinois Municipal Retirement Fund purchased a new position in Ingevity in the 1st quarter valued at $1,465,000. Institutional investors and hedge funds own 91.59% of the company's stock.

Ingevity Stock Up 0.9%

NGVT stock opened at $71.53 on Friday. The stock has a market cap of $2.46 billion, a P/E ratio of 48.66 and a beta of 1.14. The company has a current ratio of 1.61, a quick ratio of 1.15 and a debt-to-equity ratio of 22.52. Ingevity has a twelve month low of $45.85 and a twelve month high of $79.29. The company's 50 day moving average is $71.61 and its two-hundred day moving average is $71.89.

Ingevity (NYSE:NGVT - Get Free Report) last announced its quarterly earnings results on Wednesday, July 29th. The company reported $1.74 EPS for the quarter, topping the consensus estimate of $1.33 by $0.41. Ingevity had a net margin of 4.65% and a return on equity of 284.70%. The firm had revenue of $314.10 million for the quarter, compared to analyst estimates of $312.20 million. Ingevity has set its FY 2026 guidance at 5.000-5.450 EPS. Research analysts expect that Ingevity will post 5.4 earnings per share for the current fiscal year.

Ingevity Company Profile

Ingevity Corporation NYSE: NGVT is a specialty chemicals and materials company headquartered in North Charleston, South Carolina. The company develops products designed to improve environmental performance, enhance infrastructure and support industrial manufacturing.

Ingevity's products include activated carbon technologies used in automotive evaporative-emissions control systems, as well as applications involving air and water purification. The company also produces specialty chemicals and materials used in pavement preservation, asphalt modification and other industrial applications.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.